ATE506949T1 - Kombination aus andolast/glucocorticoiden - Google Patents
Kombination aus andolast/glucocorticoidenInfo
- Publication number
- ATE506949T1 ATE506949T1 AT06778075T AT06778075T ATE506949T1 AT E506949 T1 ATE506949 T1 AT E506949T1 AT 06778075 T AT06778075 T AT 06778075T AT 06778075 T AT06778075 T AT 06778075T AT E506949 T1 ATE506949 T1 AT E506949T1
- Authority
- AT
- Austria
- Prior art keywords
- glucocorticoids
- andolast
- combination
- andoalst
- calcium
- Prior art date
Links
- 239000003862 glucocorticoid Substances 0.000 title abstract 3
- 229940037128 systemic glucocorticoids Drugs 0.000 title abstract 3
- VXEBMQZDPONDFB-UHFFFAOYSA-N 4-(2h-tetrazol-5-yl)-n-[4-(2h-tetrazol-5-yl)phenyl]benzamide Chemical compound C=1C=C(C2=NNN=N2)C=CC=1C(=O)NC(C=C1)=CC=C1C=1N=NNN=1 VXEBMQZDPONDFB-UHFFFAOYSA-N 0.000 title abstract 2
- 229950002999 andolast Drugs 0.000 title abstract 2
- 102000005702 Calcium-Activated Potassium Channels Human genes 0.000 abstract 1
- 108010045489 Calcium-Activated Potassium Channels Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004036 potassium channel stimulating agent Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2006/064840 WO2008014814A1 (en) | 2006-07-31 | 2006-07-31 | Combination andolast/glucocorticoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE506949T1 true ATE506949T1 (de) | 2011-05-15 |
Family
ID=37875750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06778075T ATE506949T1 (de) | 2006-07-31 | 2006-07-31 | Kombination aus andolast/glucocorticoiden |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8809306B2 (de) |
| EP (1) | EP2054057B1 (de) |
| JP (1) | JP5220741B2 (de) |
| AT (1) | ATE506949T1 (de) |
| CA (1) | CA2659435A1 (de) |
| DE (1) | DE602006021638D1 (de) |
| ES (1) | ES2365533T3 (de) |
| PT (1) | PT2054057E (de) |
| WO (1) | WO2008014814A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013056925A (ja) * | 2012-11-21 | 2013-03-28 | Rottapharm Spa | アンドラスト／グルココルチコイドの併用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1232252B (it) | 1989-02-22 | 1992-01-28 | Rotta Research Lab | Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione |
| KR0178893B1 (ko) * | 1995-10-04 | 1999-05-15 | 김광호 | 노트북 컴퓨터의 액정 화면부 결합 힌지장치 |
| PT896821E (pt) * | 1997-08-08 | 2003-08-29 | Rotta Research Lab | Uma nova composicao farmaceutica para inalacao que contem cr 2039 (andolast) |
| GB0009613D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| CA2570386A1 (en) * | 2004-06-14 | 2005-12-29 | Sepracor Inc. | Methods of using albuterol and calcium activated potassium channel openers |
| WO2005123072A1 (en) * | 2004-06-14 | 2005-12-29 | Sepracor Inc. | Methods and compositions for the treatment of pulmonary diseases |
| EP1634595B1 (de) * | 2004-08-19 | 2008-08-13 | Rottapharm S.p.A. | Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD) |
-
2006
- 2006-07-31 PT PT06778075T patent/PT2054057E/pt unknown
- 2006-07-31 DE DE602006021638T patent/DE602006021638D1/de active Active
- 2006-07-31 US US12/375,609 patent/US8809306B2/en not_active Expired - Fee Related
- 2006-07-31 AT AT06778075T patent/ATE506949T1/de active
- 2006-07-31 EP EP06778075A patent/EP2054057B1/de not_active Not-in-force
- 2006-07-31 ES ES06778075T patent/ES2365533T3/es active Active
- 2006-07-31 JP JP2009522100A patent/JP5220741B2/ja not_active Expired - Fee Related
- 2006-07-31 WO PCT/EP2006/064840 patent/WO2008014814A1/en not_active Ceased
- 2006-07-31 CA CA002659435A patent/CA2659435A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2365533T3 (es) | 2011-10-06 |
| DE602006021638D1 (en) | 2011-06-09 |
| US20090253664A1 (en) | 2009-10-08 |
| JP2009545537A (ja) | 2009-12-24 |
| PT2054057E (pt) | 2011-05-05 |
| EP2054057B1 (de) | 2011-04-27 |
| US8809306B2 (en) | 2014-08-19 |
| CA2659435A1 (en) | 2008-02-07 |
| EP2054057A1 (de) | 2009-05-06 |
| JP5220741B2 (ja) | 2013-06-26 |
| WO2008014814A1 (en) | 2008-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
| MX2010006823A (es) | Metodos para el tratamiento de la gota. | |
| MY164646A (en) | Nicotine lozenge compositions | |
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
| DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
| LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
| MX2008013827A (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual. | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| MX2010001236A (es) | Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1). | |
| MX2009007337A (es) | Indazoles sustituidos con 5-piridinona. | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| WO2009071689A3 (de) | 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
| ATE506340T1 (de) | 12-aryl-prostaglandin-analoga | |
| CL2008002384A1 (es) | Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio. | |
| BRPI0716643A2 (pt) | amidas terapêuticas e compostos relacionados | |
| MX2010001243A (es) | Composicion anti-inflamatoria. | |
| EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
| HN2007000505A (es) | Analogos de pirazol | |
| ATE506949T1 (de) | Kombination aus andolast/glucocorticoiden | |
| WO2007116297A3 (en) | Use of aminapthone for the preparation of a medicament for treating arteriophaties | |
| WO2009043577A3 (de) | 19-nor-progesterone zur kontrazeption | |
| TN2009000448A1 (en) | Use of hdac inhibitors for the treatment of bone destruction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2054057 Country of ref document: EP |